Anal Chem by Vanrell, Luc\uc3\uada et al.
Nanopeptamers for the Development of Small-Analyte Lateral
Flow Tests with a Positive Readout
Lucía Vanrell#,‡, Andrés Gonzalez-Techera#,‡, Bruce D Hammock†, and Gualberto
Gonzalez-Sapienza#,*
#Cátedra de Inmunología, Facultad de Química, Instituto de Higiene, UdelaR, Montevideo 11600,
Uruguay
†Department of Entomology and UCD Cancer Center, University of California, Davis, California
95616, United States
Abstract
There is a great demand for rapid tests that can be used on-site for the detection of small analytes,
such as pesticides, persistent organic pollutants, explosives, toxins, medicinal and abused drugs,
hormones, etc. Dipsticks and lateral flow devices, which are simple and provide a visual readout,
may be the answer, but the available technology for these compounds requires a competitive
format that loses sensitivity and produces readings inversely proportional to the analyte
concentration, which is counterintuitive and may lead to potential misinterpretation of the result.
In this work, protein-multipeptide constructs composed of anti-immunocomplex peptides selected
from phage libraries and streptavidin/avidin as core protein, were used for direct detection of small
compounds in a non-competitive two-site immunoassay format that performs with increased
sensitivity and positive readout. These constructs that we termed “Nanopeptamers” allow the
development of rapid point-of-use tests with a positive visual endpoint of easy interpretation. As
proof of concept, lateral flow assays for the herbicides molinate and clomazone were developed
and their performance was characterized with field samples.
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Immunoassays are analytical tests that exploit the high capacity of antibodies for
recognizing target analytes with high affinity and specificity. Due to their simplicity,
sensitivity, cost-effectiveness and matrix tolerance, immunoassays have been used in
countless applications in pharmacology, food safety, environment, homeland security,
narcotics, etc.1–3 In these methods, the antigen-antibody reaction is generally coupled to a
signal generating molecule (tracer) which translates the interaction into a quantitative
readout. If the analyte is a macromolecule, typically the antigen is first captured by a
primary antibody and then detected with a secondary antibody coupled to the tracer. This
two-site format allows the use of excess concentrations of reacting antibodies, promoting the
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formation of the trivalent immunocomplex, even in the presence of trace amounts of the
analyte (high assay sensitivity). Unfortunately, this is not possible for the important group of
small analytes (drugs, metabolites, toxins, additives, pesticides, explosives, etc.), because
they cannot bind two antibodies simultaneously. The measurement of such small molecules
(immunochemically classified as haptens) is typically accomplished by competitive
reactions between the analyte and a labeled variant of the analyte in the presence of limiting
amounts of the anti-hapten antibody. This competitive format performs with inferior
sensitivity, precision, kinetics, and working range than the two-site noncompetitive format,4
and produces readouts inversely proportional to the analyte concentration, making more
difficult its adaptation into microarrays or microfluidic devices, or into rapid “on-site” visual
assays such as lateral flow tests.
Several attempts have been made to implement small-molecule noncompetitive assays, but
most of them are limited to particular chemical structures or require analyte labeling.5–7 By
focusing the recognition of the analyte-antibody immunocomplex (IC) into changes of the
hapten binding pocket upon analyte binding, we were able to isolate short-peptide loops
from phage display libraries that specifically react with the analyte-capture antibody IC.8
Using M13 phage particles displaying these peptides, we developed two-site phage anti-IC
assays (PHAIA) (figure 1A) for the herbicides molinate, atrazine and clomazone,8,9 the
drugs digoxin and cyclosporine,8 the flame-retardant brominated diphenyl ether,10 and the
pyrethroid metabolite phenoxybenzoic acid.11 Recently, other groups have also isolated anti-
IC peptides for gibberellins12 and a 1,3-diketone hapten derivative13 further showing the
general applicability of the concept. The PHAIA method provides higher sensitivity than the
conventional format (one or more orders of magnitude) and the two-site recognition also
accounts for a higher specificity.9 The phage particles proved to be robust and versatile
assay components, 14 but they are “unconventional” reagents for the immunoassay industry
and their biological nature (an E. coli infecting phage) could be a matter of concern in some
laboratories. For this reason we sought to develop PHAIA into a phage-free detection
method by using synthetic peptides designed from the anti-immunocomplex peptide
sequences isolated from phage display libraries attached to a protein scaffold. These
constructs that we termed “Nanopeptamers” allow sensitive detection of ICs and could be
developed into lateral flow tests, a feat that turned up to be particularly difficult with phage
particles due to their filamentous nature.
EXPERIMENTAL SECTION
Materials
Molinate and the thiocarbamate standards were gifts from Stauffer Chemical Co.
Thiobencarb was a gift from Chevron Chemical Co. Development of the monoclonal anti-
molinate antibody (MoAb 14D7) and anti-clomazone (MoAb 5.6) has been described in
detail previously1,2. Clomazone was purchased from Riedel-de Haen (Seelze, Germany),
high-sensitivity Streptavidin-Peroxidase (SPO) from Pierce (Rockford, IL), and Bovine
Serum Albumin (BSA), Tween 20, and 3,3′,5,5′-tetramethylbenzidine (TMB) and avidin
from Sigma (St.Louis, MO). ELISA and dilution microtiter polystyrene plates were
purchased from Greiner (Solingen, Germany). Hi-Flow Plus 120 nitrocellulose membrane
cards and cellulose absorbent pads were purchased from Millipore (Bedford, MA). Carbon
black nanoparticles were from Degussa AG (Frankfurt, Germany).
Formation of anti-molinate and anti-clomazone Nanopeptamers
Two anti-IC peptide sequences previously isolated for molinate 3 and one for clomazone 4
were produced by a commercial manufacturer (Peptron Co., Daejeon, Korea). These
peptides were synthetized to eighty percent of purity by HPLC, with intramolecular
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disulfides bonds between cysteines, an N-terminal biotin molecule and amidated C-
terminus. The synthesized peptides were: p1M, biotin-SGSGCSTWDTTGWC; pA, biotin-
SGSGCSLWDTTGWC; and pX11, biotin-SGSGCLEAPNIEGC; for molinate, molinate and
clomazone, respectively, (the anti-IC sequence is in black and the SGSG was used as
spacer). Two hundred and fifty picomoles of SPO or avidin in 100µL phosphate-buffered
saline (PBS), 1% BSA were incubated with 50, 6.5, 1.5 and 0.6 fold molar excess of
biotinylated peptides for 15 minutes on ice. The Nanopeptamers were initially separated
from the excess of biotinylated peptides by gel filtration, but this step proved to be
unnecessary.
Nanopeptamer ELISA
Microtiter plates were coated with 100 µL of the anti-herbicide monoclonal antibody in PBS
at different concentrations (10 to 2.5 µg/mL). After incubation for 1 hour at 37 °C and
blocking with PBS BSA 1% 1 hour at 37 °C, the microtiter plates were washed three times
with PBS 0.05% Tween 20 (PBST). Nanopeptamer (prepared with SPO and the
corresponding anti-IC biotinylated peptide) were diluted with PBST to the appropriate
dilution, and 50 µL were mixed with the 50 µL of the herbicide standard or water sample in
non-treated polystyrene plates (low binding capacity), transferred to the reaction microtiter
plate and incubated for 1h at room temperature. After thoroughly washing, 100 µL of the
peroxidase substrate (0.4 ml of a 6 mg/ml DMSO solution of 3,3´,5,5´-tetramethylbenzidine,
0.1 mL of 1% H2O2 in water in a total of 25 mL of 0.1 M citrate acetate buffer, pH 5.5)
were dispensed into each well. The enzyme reaction was stopped after 20 min by addition of
50 µL of 2 N H2SO4, and the absorbance was read at 450/650 nm in a microtiter plate reader
(Multiskan MS, Thermo Labsystems, Waltham, MA). Absolute or normalized values were
fitted to a four-parameter logistic equation using Genesis Lite 3.03 (Life Sciences, London)
package software.
Molinate Nanopeptamer assay cross-reactivity
The specificity of the assay was characterized with related S-thiocarbamate pesticides.
Cross-reactant concentrations in the 0–10000 ng/mL range were used in the noncompetitive
ELISAs. Standard curves were normalized by expressing experimental absorbance values
(B), as (B/B0) ×100, where B0 is the absorbance value at zero analyte concentration, and the
molar concentration corresponding to the midpoint of the curve, SC50), was used to express
the cross-reactivity of the assay according to the equation % cross-reactivity = 100 × [SC50
(analyte) / SC50 (cross-reacting compound)]
Carbon black avidin labeling
A 5% solution of carbon black in MilliQ water was homogenized in sonication water bath,
and was diluted 25 fold with 5 mM boric buffer, pH 8.8. One hundred µL of avidin (4 mg/
mL) in 5 mM boric buffer, pH 8.8 were combined with 900 µL of 0.2% carbon black and
incubated for 3 h at room temperature. The suspension was then centrifuged a 14,000 rpm
for 15 min and the pellet resuspended in 1 mL of 100 mM boric buffer, pH 8.8, 0.02%
Tween 20 by sonication. After repeating this step three more times, the carbon-labeled
avidin was resuspended in 1 mL of 100 mM boric buffer, pH 8.8, 0.02% Tween 20, and
used to prepare the Nanopeptamers as described below.
Lateral Flow Immunocromatography
MoAb 14D7 or MoAb 5.6 lines were printed on Hi-Flow Plus 120 nitrocellulose membrane
cards at 0.92 µg/cm using a BioDot AD 1500 Liquid Dispenser. Avidin was labeled with
carbon black nanoparticles as described. Approximately 40 µg (100 µL) of carbon black
labeled avidin was preincubated with 15 µg of pA or pX11 (6 µL, 2.5 mg/mL in DMSO) in a
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final volume of PBS containing 0.025 % Tween-20. After incubation for 15 min on ice, 2.5
µL of this carbon black labeled Nanopeptamers mixture were transferred to microtiter plate
wells containing 100 µL of PBS, 0.025% Tween previously spiked with known amounts of
molinate and clomazone standards. Hi-Flow Plus 120 nitrocellulose membrane cards
(printed with MoAbs 14D7 or 5.6) assembled with an absorbent cellulose pad were dipped
into the wells and let stand for 10 minutes. After that, the strips were read for the formation
of a visible reaction line by the naked eye by four independent observers in three different
repetitions of the tests. Molinate assays were validated by performing spiking in runoff
water samples of agricultural areas of Uruguay (95 µL water sample + 5 µL PBS × 10,
0.025% Tween 20), and measuring them with strips as described above.
RESULTS AND DISCUSION
Anti-IC peptides can react specifically with ICs when displayed in a multivalent manner
As starting model system we used the thiocarbamate herbicide molinate, the anti-molinate
monoclonal antibody 14D715 and the anti-IC synthetic peptides p1M (biotin-
SGSGCSTWDTTGWC) and pA (biotin-SGSGCSLWDTTGWC). Both peptides were
previously isolated from phage libraries panned against the molinate-14D7 IC. Peptide pA,
which differs only by having Leu in position 7th, was isolated from a mutagenesis library
derived from the p1M sequence, and while performing with similar sensitivity in PHAIA
tests, showed less residual cross-reactivity with the unliganded antibody 8. Initial ELISA
experiments aimed at detecting binding of the biotynilated peptides to the molinate-
MoAb14D7 IC failed. This was assumed to be caused by the loss of the avidity effect
inherent to the display of the peptide on pVIII. This prompted us to express the peptides as
N-terminal fusion with the E. coli alkaline phosphatase that forms dimers and therefore a
ows bivalent display of the peptides, but only marginal reactivity with the IC was observed
(not shown). In order to further increase the avidity of the interaction, we used the tetrameric
structure of streptavidin as scaffold for tetravalent display of the biotinylated synthetic
peptides. These streptavidin-peptide complexes, that we termed ‘Nanopeptamers’, have the
additional advantage that several ready-to-use streptavidin commercial conjugates exist,
which can be used as versatile signal-generation elements (figure 1).
Preliminary experiments with different commercial streptavidin-peroxidase conjugates
showed the best results when streptavidin conjugated to a polymeric form of horse radish
peroxidase conjugated to streptavidin (SPO, high-sensitivity Streptavidin-Peroxidase, Pierce
(Rockford, IL)) was used. The Nanopeptamers were initially formed by using an estimated
50-fold molar excess of biotinylated peptide and their reactivity was assayed in microtiter
plates coated with MoAb 14D7, in the presence or absence of molinate. Similarly to what
we observed with anti-IC phage, the Nanopeptamers reacted specifically with the IC but
showed some residual reactivity with the uncombined antibody. This cross-reactivity was
more evident at high concentrations of Nanopeptamers and high density of coating antibody
(figure S-1, Supporting Information). Since these conditions (excess of reagents) are
expected to provide the best assay sensitivity, a trade-off selection of these parameters needs
to be done by checkerboard experiments. This is exemplified in figure S2 (Supporting
Information) where increasing concentrations of the Nanopeptamer (SPO-pA) improve the
assay sensitivity but it also shows that the background signal at zero concentration of analyte
deteriorates after a certain point due to the residual cross-reactivity with the uncombined
antibody. The influence of the peptide to SPO ratio on assay performance was also studied.
The formation of the streptavidin-biotin complex is fast, and due to the exceptionally high
affinity of the interaction,16 it is expected that rapidly after mixing all the biotinylated
peptide is complexed. However, since the exact stoichiometry of the SPO commercial
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polymeric conjugate is unknown, the amount of saturating biotynilated peptide was
determined empirically (figure S-3, Supporting information).
PHAIA and Nanopeptamer ELISAs perform in a similar way
After optimization of these parameters, both Nanopeptamers (SPO-pA and SPO-p1M) were
used to develop noncompetitive assays for molinate, figure 2. The dose response curves had
a typical sigmoid shape with signal saturation at high concentration of molinate. The
midpoint corresponding to the concentration of analyte giving 50% of signal saturation
(SC50) were 8.3 ± 0.2 and 10.0 ± 0.3 ng/ mL, and the limit of detection (LOD = analyte
concentration giving a 10% increase over the zero signal) were 1.2 and 3.2 ng/mL for
Nanopeptamers pA and p1M, respectively. The LOD attained with the Nanopeptamers were
up to 18 fold better than that of the competitive ELISA set up with the same antibody (LOD
22 ng/mL, IC50 69 ± 0.5 ng/mL).15
The SC50 obtained with Nanopeptamer p1M was not as good as the SC50 obtained in the
PHAIA format (SC50 = 5.0 ± 0.4 ng/mL), but this was not the case for the pA complex that
performed with a SC50 value equal to that obtained with the phage borne peptide (8.5 ± 0.5
ng/mL).8 Based on these results, Nanopeptamer pA was then used to characterize the cross-
reactivity, matrix interference and for adaptation of the Nanopeptamer assay to other
formats. Cross-reactivity was tested using a panel composed of common agrochemicals
utilized in rice culture (quinclorac, glyphosate, molinate, bispiribac, propanil, and atrazine),
as well as other S-thiocarbamate pesticides, table 1. Only minor cross-reactivity with closely
related thiocarbamate compounds was observed, which was similar to that obtained with the
PHAIA assay. Likewise, no matrix effect was observed when standard molinate curves were
performed with undiluted agricultural run off-water samples from different areas of Uruguay
(figure S-4, Supporting Information).
Nanopeptamers allow the development of noncompetitive lateral-flow tests
A major advantage of noncompetitive assays is that they can be developed into simple
formats with a positive visual endpoint. Our initial attempts to adapt PHAIA into lateral-
flow assays were not successful, most probably due to the filamentous nature of the phage
that promoted the formation of aggregates with the colloidal labels. Fortunately, this
limitation was overcome using Nanopeptamers. Figure 3A shows the results of a lateral-flow
assay set up using MoAb 14D7 as capture reagent immobilized on polyester-backed
nitrocellulose membranes and colloidal-carbon labeled avidin complexed to pA for detection
(see supporting information). For the sake of comparison, we also developed the molinate
assay in a lateral-flow competitive format using MoAb 14D7 as capture antibody and the
molinate derivative 7b (S-2-(p-aminophenyl)-ethyl-hexahydroazepine-1-carbothioate)
coupled to conalbumin, which was labeled with colloidal carbon for detection, figure 3B. A
molinate concentration of 2.5 ng/mL caused a visible test line in the noncompetitive assay,
while 32 ng/mL produce a weaker test line than the negative control in the competitive
assay; as was agreed upon by four independent observers in three different repetitions of the
test. This is in agreement, with the densitometry analysis of the strips, table S-1A
(Supporting Information). In addition to the positive reading, the noncompetitive test
performed with a 10 fold improved sensitivity. The assay was then tested for matrix
interference using ten runoff water samples from agricultural areas of Uruguay spiked with
0, 1.0, 1.5, 2.5, 5, and 20 ng/mL of molinate. The strips were read by four independent
observers, all of whom detected a visible reaction line with concentrations of 2.5 ng/mL or
higher, figure S-5 (Supporting information).
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Nanopeptamer based ELISA and lateral-flow test for clomazone
To explore the general utility of the method, we also developed Nanopeptamer-based assays
for the herbicide clomazone. To this end we used the anti-clomazone MoAb 5.6 17 and the
anti-IC synthetic peptide X11 (biotin-SGSGCLEAPNIEGC) complexed with SPO or avidin.
This peptide has been previously isolated from phage libraries panned against the
clomazone-MoAb 5.6 IC.9 For ELISA, the assay conditions were optimized essentially as
described for the molinate test, which allowed to obtain a LOD = 1.2 ng/mL and SC50 = 3.4
± 0.2 ng/mL using SPO-pX11 (figure 4A). This represents an improvement of 3.3 and 8.3-
fold regarding the assay set up with the same antibody in a competitive format (LOD = 4 ng/
ml and IC50 = 28 ± 1.1 ng/mL, respectively).17 The assay was also adapted into a lateral-
flow format using avidin-pX11 labeled with carbon black, which allowed to detect up to 2.5
ng/mL of clomazone (figure 4B); the densitometry data is shown in table S-1B.
Conclusions
Our results show that in spite of big structural differences, the streptavidin/avidin-based
Nanopeptamer properly reproduces the binding characteristics of the phage particles.
Indeed, the dihedral D2 molecular symmetry of the streptavidin homo-tetramer positions
two pairs of biotin binding sites on opposite faces of the protein, and thus the distance
between the biotin carboxylated oxygens that anchor the peptides are ~2 nm on the same
face, and ~3 nm on opposite faces of the complex.18 On the other hand, M13 has a ~6 ×
1000 nm rod-like structure, covered by ~2700 copies of the minor protein pVIII arranged in
a fish-scale pattern, and the use a phagemid system for the generation of the virons yields
phage particles with approximately 200 copies of pVIII expressing the peptide, meaning an
average distance between peptides close 10 nm.19 In addition, the peptide is tethered in a
different way in both systems. For the sake of simplicity, the peptides were synthesized with
a biotin residue added to their N-terminus, while they are expressed as pVIII N-terminal
fusions on the phage. Considering the differences in valences and display features of both
systems, it seems that the specific recognition of the IC by the peptide can be transferred out
of the ‘phage context’ with a considerable degree of flexibility.
As demonstrated here, the availability of phage-free reagents for noncompetitive assays
could have a major impact in the development of rapid two-site tests for small molecules
with a positive visual endpoint, a feat not possible with the available technology. Since the
strategy for the selection of anti-IC phage borne peptides is well established, and
considering the varied offer commercially available streptavidin conjugates, Nanopeptamers
may be the long-sought detection reagent for the development of fast noncompetitive assays
for small analytes. In that sense a major proof of concept contributed by our work is their
use in the development of lateral flow test for small molecules with a positive reading
improving the sensitivity and interpretability of these tests.
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Scheme of PHAIA (phage anti-immunocomplex assay) and the Nanopeptamer
noncompetitive assays. Panel A shows the scheme of PHAIA that typically uses filamentous
M13 phage (light green) expressing disulfide constrained peptides (~100–200 copies along
the ~2700 copies of the coat protein pVIII). Binding of the phage to the analyte-antibody
(light blue) immunocomplex is detected with an anti-M13 antibody (pink) coupled to horse
radish peroxidase (PO). Panel B schematizes the substitution of the phage particle by a
Nanopeptamer (a streptavidin conjugate, combined with four molecules of the biotinylated
peptide)
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Noncompetitive Nanopeptamer ELISA for molinate using peptides pA and p1M. MoAb
14D7 (10 µg/mL) was used for coating and SPO (0.75 µg/mL) complexed with a 50 fold
molar excess of pA (triangles) or p1M (circles) was used for detection.
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Noncompetitive Nanopeptamer pA-based (A) and competitive (B) lateral-flow assays for
molinate. The nitrocellulose strips were tested with buffer containing various concentrations
of molinate (ng/mL) as denoted in the figure.
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Noncompetitive Nanopeptamer ELISA and lateral-flow test for clomazone using peptide
pX11. A) MoAb 5.6 (10 µg/mL) was used for coating and SPO (0.75 µg/mL) complexed
with a 50 fold-molar peptide excess for detection. B) Nitrocellulose strips were tested with
buffer containing various concentrations of clomazone (ng/mL) as denoted in the lower part
of the figure.
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Table 1
Cross reactivity (%) of Nanopeptamer pA and PHAIA assays with related thiocarbamate pesticides.








All data are the mean of two independent experiments. A value of 0 means that there was no observable cross-reactivity at the highest
concentration tested 104 ng/mL
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